2016
DOI: 10.1016/j.lfs.2016.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Evidence that diclofenac and celecoxib are thyroid hormone receptor beta antagonists

Abstract: These results highlight the benefits of computational chemistry methods used to retrospectively analyse well known drugs for side effects. Using in silico and in vitro methods we have shown that both celecoxib and diclofenac but not naproxen exhibit off-target TRβ antagonist behaviour, which may be linked to their detrimental side effects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 35 publications
(33 reference statements)
1
6
0
Order By: Relevance
“…In addition, the 1-h relaxation time in the myography chamber might reduce the available intracellular T3 and T4 concentrations, which would affect the hyperthyroid conditions more than the euthyroid conditions and could obscure subtle effects. Nevertheless, impaired relaxation has been observed previously in mice expressing a mutant TRβ (Owen et al 2007), and blocking TRβ in mesenteric arteries inhibited the T3-induced nongenomic vasodilation (Zloh et al 2016). Taken together, these findings suggest that activation of TRβ might be beneficial for aortic stiffness, a notion that is supported by reports that the TRβ-selective agonist GC-1 delays the onset of atherosclerosis in ApoE-deficient mice (Kannisto et al 2014).…”
Section: Role Of Th Receptor βsupporting
confidence: 77%
“…In addition, the 1-h relaxation time in the myography chamber might reduce the available intracellular T3 and T4 concentrations, which would affect the hyperthyroid conditions more than the euthyroid conditions and could obscure subtle effects. Nevertheless, impaired relaxation has been observed previously in mice expressing a mutant TRβ (Owen et al 2007), and blocking TRβ in mesenteric arteries inhibited the T3-induced nongenomic vasodilation (Zloh et al 2016). Taken together, these findings suggest that activation of TRβ might be beneficial for aortic stiffness, a notion that is supported by reports that the TRβ-selective agonist GC-1 delays the onset of atherosclerosis in ApoE-deficient mice (Kannisto et al 2014).…”
Section: Role Of Th Receptor βsupporting
confidence: 77%
“…Hwang et al 67 found a significant antagonistic effect of MLS on human THRB in gene reporter assays using the human kidney cell line HEK293 at concentrations of 10 and 20 μM MLS in the presence of 30 nM T3. Zloh et al 68 also reported a significant antagonistic effect of MLS on human THRB using 10 μM MLS in the presence of 100 nM T3, using a mammalian cell line, which was not further specified. The explanation for the absence of inhibition of wTHRB transcriptional activity by MLS remains unclear.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…However, as it is the case with other classical NSAIDs, increased risk of gastrointestinal mucosa ulceration and bleeding is one of the most important side effects of diclofenac, which is due to the decreased production of locally protective COX-1-derived prostanoids, such as PGE 2 and prostacyclin (PGI 2 ) (11). In this way, selective COX-2 inhibitors are devoid of these deleterious effects (12). Of these, etoricoxib (available in some European countries, Latin-America and in the Asia-Pacific region) is used for pain relief and treatment of chronic inflammatory diseases.…”
Section: Introductionmentioning
confidence: 99%